Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase

FERNÁNDEZ, ARIEL

ACS Pharmacology and Translational Science

American Chemical Society

Año: 2021 vol. 4 p. 410 - 412

There is a need to assess evolutionary outcomes for SARS-CoV-2 in the postvaccination phase. The role of virus glycosylation in deterring the development of vaccine resistance is weighed against the epitopes of extant vaccines and the modulation of induced immune surveillance on antigens containing glycosylation sites.